Thrombolytic therapy for acute ischemic stroke: 3 h and beyond

References

• Hacke W, Del Zoppo GJ, Harker LA. Thrombosis and cerebrovascular disease. In: Recent Advances in Diagnosis and Management of Stroke. Poeck K, Ringelstein EB, Tacke W (Eds). Springer-Verlag, NY, USA, 59–64 (1987).
   Google Scholar
• Fieschi C, Argentino C, Lenzi GL et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J. Neurol. Sci. 91, 311–321 (1989).
   PubMed Web of Science ®Google Scholar
• Collins RC, Dobkin BH, Choi DW. Selective vulnerability of the brain: new insights of the brain: new insights into the pathophysio logy of stroke. Ann. Intern. Med. 110, 992–1000 (1989).
   PubMed Web of Science ®Google Scholar
• Shivaishi K, Sharp FR, Simon RP. Sequential metabolic changes in rat brain following middle cerebral artery occlusion: a 2-deoxyglucose study. J. Cereb. Blood Flow Metab. 9, 765–773 (1989).
   PubMedGoogle Scholar
• Sussman BJ, Fitch TSP. Thrombolysis with fibrinolysin in cerebral arterial occlusion JAMA 167, 1705–1709 (1958).
   PubMed Web of Science ®Google Scholar
• The National Institute of Neurological Disorders and stroke rt-PA stroke study group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333, 1581–1587 (1995).
   PubMed Web of Science ®Google Scholar
• Clarke RL, Clifton E. The treatment of cerebro vascular thromboses and embolism with fibrinolytic agents. Am. J. Cardiology 6, 546–551 (1960).
   PubMedGoogle Scholar
• Herndon RM, Meyer JS, Johnson JF. Fibrinolysin therapy in thrombotic diseases of the nervous system. J. Mich. Med. Soc. 59, 1684–1692 (1960).
   PubMedGoogle Scholar
• Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Anticoagulants plus streptokinase therapy in progressive stroke. JAMA 189, 373 (1964).
   Google Scholar
• Meyer JS, Gilroy J, Barnhart MI, Johnson JF. Therapeutic thrombolysis in cerebral thromboembolism. Neurology 13, 927–937 (1963).
   PubMed Web of Science ®Google Scholar
• Fletcher AP, AIK Jersig N, Lewis M et al. A pilot study of urokinase therapy in cerebral infarction. Stroke 7, 135–142 (1976).
   PubMedGoogle Scholar
• Doman GA, Dan’s SM, Chambers BR et al. Trials of streptokinase in severe acute ischemic stroke. Lancet 345, 578–579 (1995).
   Google Scholar
• The Multicenter Acute Stroke Trial – Europe Study Group: thrombolytic ischemic stroke. N. Engl. J. Med. 335, 145–150 (1996).
   PubMed Web of Science ®Google Scholar
• Multicenter Acute Stroke Trial – Italy (MAST-I) Group. Randomized controlled trial of streptokinase, aspirin and combination of both in treatment of acute ischemic stroke. Lancet 346, 1509–1514 (1995).
   PubMed Web of Science ®Google Scholar
• Donnan GA, Dans SM, Schambers BR et al for the Australian streptokinase (ASK) Trial study Group. Streptokinase for acute ischemic stroke with relationship to time of administration. JAMA 276, 961–966 (1996).
   PubMed Web of Science ®Google Scholar
• Hommel M, Boissel JP, Comu C et al for the MAST study Group. Termination of trial of strepto kinase in severe acute ischemic stroke. Lancet 315, 57 (1994).
   Google Scholar
• Hacke W, Kaste M, Fieshi C et al. Intrarenous thrombolysis with recmbinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute stroke study (ECASS). JAMA 274, 1017–1025 (1995).
   PubMed Web of Science ®Google Scholar
• Hacke W, Kaste M, Eieschi C et al. Randomized double blind placebo-controlled trial of thrombolytic therapy with intravenous atteplase in acute ischemic stroke (ECASS II). Second European–Australasion-Acute stroke study Investigators. Lancet 352, 1245 –1251 (1998).
   PubMedGoogle Scholar
• Clark WM, Wissman S, Albers GW et al. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset: the ATLANTIS study: a randomized controlled trial. Afteplase thrembolysis for Acute Nonintervention Therapy in Ischemic stroke. JAMA 282, 2019–2026 (1999).
   PubMed Web of Science ®Google Scholar
• Albers GW, Clark WM, Madden KP et al. ATLANTIS trial: results for patients treated within 3 hours of stroke onset. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic stroke. Stroke 33, 493–496 (2002).
   PubMed Web of Science ®Google Scholar
• Marler JR, Tilley BC, Lu M et al. Early stroke treatment associated with better outcome: NINOS rtPA stroke study. Neurology 55, 1649–1655 (2000).
   PubMed Web of Science ®Google Scholar
• Albers GW, Bates VE, clark WM et al. Intravenous tissue- type plasminogen activator for treatment of acute stroke: the standard treatment with alteplase to reverse stroke (STARS) study. JAMA 283, 1145–1150 (2000).
   PubMed Web of Science ®Google Scholar
• Hill MD, Buchan AM. Methodology for the Canadian Activase for stroke effectiveness study (CASES). CASES Investigators. Can. J. Neurol. Sci. 8, 232–238 (2001).
   Google Scholar
• Ground M, Stenzel C, Schmulling S et al. Early intravenous thrombolysis for acute ischemic stroke in a community-based approach. Stroke 29, 1544–1549 (1998).
   PubMedGoogle Scholar
• Chiu DKD, Villar-Cordova C. Intravenous tissue plasminogen activator for acute ischemic stroke. Stroke 29, 18–22 (1998).
   PubMed Web of Science ®Google Scholar
• Trouillar P, Nighoghossian N, Derex L et al. Thrombolysis with intravenous rtPA in a series of 100 cases of acute carotid territony stroke: determination of etiological, topographic and radiological outcome factors. Stroke 29, 2529–2540 (1998).
   PubMedGoogle Scholar
• Tanne D, Bates VE, Verro P et al. Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke; a multicenter survey. The rtPA-Stroke Survey Group. Neurology 53, 424–427 (1999).
   PubMed Web of Science ®Google Scholar
• Akins PT, Delemos C, Wentworth D et al. Can emergency department physicians safely and effectively initiate thrombolysis for acute ischemic stroke? Neurology 55, 1801–1805 (2000).
   PubMed Web of Science ®Google Scholar
• Katzan I, Furlan AF, Lioyd LE et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. JAMA 283, 1151–1158 (2000).
   PubMed Web of Science ®Google Scholar
• Wang DZ, Rose JA, Honings DS. Treating acute stroke patients with intravenous rtPA: the OSF stroke network experience. Stroke 31, 77–81 (2000).
   PubMed Web of Science ®Google Scholar
• Lopez–Yunez A, Bruno A, Williams L et al. Protocol violations in community-based rtPA stroke treatment are associated with symptomatic intracerebral hemontage. Stroke 32, 12–16 (2001).
   PubMedGoogle Scholar
• Bravata DM, Kim N, Concata J et al. Thrombolysis for acute stroke in routine clinical practise. Arch. Intern. Med. 162, 1994–2001 (2002).
   PubMed Web of Science ®Google Scholar
• Merino JG, Silver B, Wong E et al. Extending tissue plasminogen activator use to community and rural stroke patients. Stroke 33, 141–146 (2002).
   PubMed Web of Science ®Google Scholar
• Tanne D, Kasner SE, Demchuk AM et al. Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey. Circulation 105, 1679–1685 (2002).
   PubMed Web of Science ®Google Scholar
• Hacke W, Bluhinki E, Steiner T et al. Dichotomized efficacy end points ECASS intention to treat data set: analysis of ECASS I. Stroke 29, 2073–2075 (1998).
   PubMed Web of Science ®Google Scholar
• Fiorelli M, Bastiasello S, von Kummer R et al. Hemorhagic transformation within 36 hours of a cerebral infarct: relationships with early clinical determination and 3 months outcome in the European Cooperative Acute Stroke Study I (ECASI) cohort. Stroke 30, 2280–2284 (1999).
   PubMed Web of Science ®Google Scholar
• Larnue V, Von Kummer R, Del Zoppo G, Blutimki E. Hemorrhagic transformation in acute ischemic stroke: potential contributing factors in the European Cooperative Acute stroke study. Stroke 28, 957–960 (1997).
   PubMedGoogle Scholar
• Del Zoppo GJ, Higastida RT, Furlan AJ et al. PROACT: a phase II randomized trial of recobinant pro-urokinase by direct delivery in acute middle cerebral artery stroke. Stroke 29, 4–11 (1999).
   Google Scholar
• Furlan A, Higastida R, Wechsler L et al. Intra arterial prourokinase for acute ischemic stroke: the PROACT II study; a randomized controlled trail. Prolyse in acute cerebral thromboembolism. JAMA 282, 2003–2011 (1998).
   Google Scholar
• Berridge DC, Makin GS, Hopkinson BR. Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage. Br. J. Surg. 76, 1230–1233 (1989).
   PubMed Web of Science ®Google Scholar
• Casto L, Caverni L, Canerlingo M et al. Intra-arterial thrombolysis in acute ischemic stroke: experience with a superselective catheter embedded in the eltot. J. Neurol. Neurosug. Psychiatry 60, 667–670 (1996).
   PubMed Web of Science ®Google Scholar
• Wijdicks EF, Nichols DA, Thielen KR et al. Intra-arterial thrombolysis in acute basilar artery thromboembolism: the initial Mayo clinic experience. Mayo Clin. Proc. 72, 1005–1013 (1999).
   Google Scholar
• Cronner F, Renonda L, Mattle H et al. Local intra-arterial cerebral thrombolysis in acute ischemic stroke. Stroke 29, 1894–1900 (1998).
   PubMedGoogle Scholar
• Edwards MT, Murphy MM, Geraghty JJ et al. Intra-arterial cerebral thrombolysis for acute ischemic stroke in a community hospital. AJNR Am. J. Neuroradiol. 20, 1682–1687 (1999).
   PubMed Web of Science ®Google Scholar
• Katzan IL, Masaryk TJ, Furhan AJ et al. Intra-arterial thrombolysis for perioperative stroke after open heart surgery. Neurology 52, 1081–1084 (1997).
   Google Scholar
• Suarez JI, Sunshine JL, Tarr R et al. Predictors of clinical improvement, angiographic recanalization, and intra cranial hemorrhage after intra-arterial thrombolysis for acute ischemic stroke. Stroke 30, 2094–2100 (1999).
   PubMed Web of Science ®Google Scholar
• Schellinger PD, Fiebach JB, Mohr A et al. Thrombolytic therapy for ischemic stroke: a review; part II: intra-arterial thrombolysis, vertbrobasilar stroke, phase IV trials and stroke imaging. Crit. Care Med. 29, 1819–1825 (2001).
   PubMed Web of Science ®Google Scholar
• Slinka U, Mull M, Stelzer A et al. Long-term follow-up of patients after intra-arterial thrombolytic therapy of acute vertebrobasilar artery occlusion. Cerebrovasc. Dis. 12, 214–219 (2001).
   PubMedGoogle Scholar
• Aronold M, Nedeltchev K, Sturzenegger M et al. Thrombolysis in patients with acute stroke caused by cervical artery dissection: analysis of 9 patients and review of the literature. Arch. Neurol. 59, 549–553 (2002).
   PubMedGoogle Scholar
• Branelt T. Diagnosis and thrombolytic therapy of acute basilar artery occlusion: a review. Clin. Exp. Hypertens. 24, 611–622 (2002).
   PubMedGoogle Scholar
• Kidwell CS, Saver JL, Carneado J et al. Predictors of hemorrhagic transformation in patients receiving intra-arterial thrombolysis. Stroke 33, 717–724 (2002).
   PubMed Web of Science ®Google Scholar
• Furlar AJ. Natural history of atherothromboembolic occlusion of cerebral arteries: carotid versus vertebrobasilar territories. In: Thrombolytic Therapy in Acute Ischemic Stroke. Hacke W, del Zoppo GJ, Hirschberg M (Eds). Spinger–Verlag, NY, USA, 71–76 (1991).
   Google Scholar
• Hacke W, Zeumer H, Ferbet A et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebro basilar occlusive disease. Stroke 19, 1216–1222 (1998).
   Google Scholar
• Schumacher M, Siekmann R, Radu W, Wakhloo AK. Local intra-arterial fibrinolytic therapy in vertebrobasilar occlusion. In: Advances in Neurosurgery. Bauer BL, Brock M, Klinger M (Eds). 22, 30–34 (1994).
   Google Scholar
• Brandt T, Von Kummer R, Muller Kuppers M et al. Thrombolytic therapy of acute basilar artery occlusion, variables affecting recanalization and outcome. Stroke 27, 875–881 (1996).
   PubMed Web of Science ®Google Scholar
• Huemer M, Niederwieser V, Ladurner G. Thrombolytic treatment for acute occlusion of the basilar artery. J. Neurol. NeuroSurg. Psychiatry 58, 227–228 (1995).
   PubMed Web of Science ®Google Scholar
• Becker KJ, Monsein LH, Ulatowski J et al. Intra-arterial thrombolysis in vertebrobasilar occlusion. AJNR 17, 255–262 (1996).
   PubMed Web of Science ®Google Scholar
• Cross DT, Moran CIJ, Akins P et al. Relationship between clot location and outcome after basilar artery thrombolysis. AJNR 18, 1221–1228 (1997).
   PubMedGoogle Scholar
• Hacke W, Brott T, Caplan L et al. Thrombolysis in acute ischemic stroke: controlled trials and clinical experience. Neurology 53, S3–S14 (1999).
   PubMed Web of Science ®Google Scholar
• Wardlaw J, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischemic stroke (Cocharane review). Cochrane Database Syst. Rev. 2, CD 000213 (2000).
   Google Scholar
• Ringleb PA, Schellinger PD, Schranz C, Hacke W. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke. Useful or harmful? Stroke 33, 1437–1449 (2002).
   PubMed Web of Science ®Google Scholar
• Fisher M. Characterizing the target of acute stroke treatment. Stroke 28, 866–872 (1999).
   Google Scholar
• Beaulieu C, Moseley ME. Diffusion-weighted and perfusion-weighted magnetic resonance imaging in clinical stroke. In: Current Review of Cerebrovascular Disease. Fourth Edition. Fisher M, Bogousslavsky J (Eds). Current Medicine, PA, USA, 59–68 (2001).
   Google Scholar
• Schlaug G, Benfield A, Baird AE et al. The ischemic penumbra: operationally defined by diffusion perfusion MRI. Neurology 53, 1528–1537 (1999).
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Alger JR, Saver JL. Beyond mismatch: evolving paradigms in imaging the ischemic penumbra with multimodal magnetic resonance imaging. Stroke 34, 2729–2735 (2003).
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Saver JL, Mattiello J et al. Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging. Ann. Neurol. 47, 462–469 (2000).
   PubMed Web of Science ®Google Scholar
• Li F, Liu KF. Secondary decline in apparent diffusion coefficient and neurological outcome after a short period of focal brain ischemia in rats. Ann. Neurol. 48, 236–244 (2000).
   PubMedGoogle Scholar
• Parsons MW, Barber PA, Chalk J et al. Diffusion and perfusion-weighted MRI response to thrombolysis in stroke. Ann. Neurol. 51, 28–37 (2002).
   PubMed Web of Science ®Google Scholar
• Neumann-Haeflin T, de Rochemont M, Fiebach JB et al. Effect of incomplete (spontaneous and postthrombolytic) recanalization after middle artery occlusion. Stroke 35, 109–115 (2004).
   PubMedGoogle Scholar
• Fisher M, Davalos A. Emerging therapies for cerebrovascular disorders. Stroke 35, 367–369 (2004).
   PubMedGoogle Scholar
• Eastwood JD, Lev MH, Provenzale JM. Perfusion CT with iodinatd contrast material. AJR 180, 3–12 (2003).
   PubMed Web of Science ®Google Scholar
• Wintermark M, Reichhart M, Thiran JP et al. Prognostic accuracy of cerebral blood flow measurement by perfusion computed tomography, at the time of emergency room admission, in acute stroke patients. Ann. Neurol. 51, 417–432 (2000).
   Google Scholar
• Grotta JC. Combination therapy stroke trial: rtPA +/- lubeluzole. Stroke 31, 278 (2002).
   Google Scholar
• Lyden PD, Astiwood T. The Clomethole Acute Stroke study in Ischemic, Hemorrhage, and tPA treated stroke: design of a phase III trial in the United States and Canada. J. Stroke Cerebrovasc. Dis. 6, 435–441 (1998).
   Google Scholar
• Albers GW, Amarenco P, Easton JD, Sacco Rl, Teal P. Antithrombotic and thrombolytic therapy for ischemic stroke. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126, S483–S512 (2004).
   PubMed Web of Science ®Google Scholar